英皇資本集團有限公司董事會（「董事會」）成員載列如下 : 執行董事 楊玳詩女士 （主席） 朱允明先生 范敏嫦女士 獨立非執行董事 （於百慕達註冊成立之有限公司） （股份代號: 717） 董事名單與其角色和職能 董事會 黃德明先生 余擎天先生 陳嬋玲女士 附註: C 主席 M 成員 香港，2026年1月1日 董事委員會 董事會設立五個委員會。下表提供董事會成員在這些委員會中所擔任的職位。 | | 董事 委員會 | 審核委員會 | 薪酬委員會 | 提名委員會 | 企業管治 | 執行委員會 | | --- | --- | --- | --- | --- | --- | --- | | 董事 | | | | | 委員會 | | | 楊玳詩女士 | | | | M | | C | | 朱允明先生 | | | | | | M | | 范敏嫦女士 | | | M | | C | M | | 黃德明先生 | | M | C | M | | | | 余擎天先生 | | C | M | | M | | | 陳嬋玲女士 | | M | | C | M | | ...

消息面上，英皇资本昨晚公布截至2025年9月30日止年度业绩，总收入约7.3亿港元，同比增长37.3%； 净溢利约1.47亿港元，同比增长121.4%；每股基本盈利为2.18港仙。不派末期息。该集团指，总收入约 7.3亿港元，升37.3%，因继续坚守审慎方针，采用严谨信贷风险管理及监控机制，以降低违约风险，根 据市况及时调整利率及贷款估值比率，贷款分部收入约1.8亿港元，跌25%，占总收入的24.7%。孖展贷 款、其他贷款及垫款的减值拨备净额大幅减少至约4320万港元。 英皇资本(00717)绩后低开逾5%，截至发稿，跌5.61%，报0.101港元，成交额21.27万港元。 ...

消息面上，英皇资本昨晚公布截至2025年9月30日止年度业绩，总收入约7.3亿港元，同比增长37.3%； 净溢利约1.47亿港元，同比增长121.4%；每股基本盈利为2.18港仙。不派末期息。该集团指，总收入约 7.3亿港元，升37.3%，因继续坚守审慎方针，采用严谨信贷风险管理及监控机制，以降低违约风险，根 据市况及时调整利率及贷款估值比率，贷款分部收入约1.8亿港元，跌25%，占总收入的24.7%。孖展贷 款、其他贷款及垫款的减值拨备净额大幅减少至约4320万港元。 智通财经APP获悉，英皇资本(00717)绩后低开逾5%，截至发稿，跌5.61%，报0.101港元，成交额21.27 万港元。 ...

Company News - Emperor Capital (00717.HK) reported total revenue of approximately HKD 730 million for the year ending September 30, 2025, representing a year-on-year increase of 37.3%. Net profit reached approximately HKD 147 million, up 121.4% year-on-year [2] - New Special Energy (01799.HK) plans to sell a 79.92% stake in Xinjiang Wind Power New Energy Partnership for approximately HKD 1.337 billion to facilitate a REITs issuance [2] - Bay Area Development (00737.HK) signed a construction contract for the Shenzhen section with a contract value of RMB 1.448 billion [2] - Weichai Power (03393.HK) won a bid for the Brazil CPFL project with a contract amount exceeding HKD 80 million [3] - WuXi AppTec (02359.HK) invested approximately EUR 30 million to acquire a 3.22% stake in a French biopharmaceutical fund [3] - Joy Spreader Group (02473.HK) established a long-term strategic cooperation with New Stone Technology in areas such as autonomous vehicle procurement and market promotion [3] - Fosun Pharma (02196.HK) signed a cooperation and option agreement with Clavis Bio to jointly advance preclinical development of selected target compounds [3] - CSPC Pharmaceutical Group (01093.HK) reported top-line analysis data from the Phase III clinical trial of its drug, Truxima [3] - Yihai International (01662.HK) announced a strategic cooperation between Trio AI and HGC [4] Financing and Buyback Activities - Zhi Yuan Holdings (00990.HK) plans to issue a total of 515 million new shares at a discount of approximately 1.4%, aiming to raise about HKD 355.3 million [5] - Tencent Holdings (00700.HK) repurchased 1.055 million shares for HKD 636 million, with buyback prices ranging from HKD 599.5 to HKD 605.5 [5] - Xiaomi Group-W (01810.HK) repurchased 3.75 million shares for HKD 151 million, with buyback prices between HKD 40.12 and HKD 40.24 [6] - COSCO Shipping Holdings (01919.HK) repurchased 5.9 million shares for HKD 80.6 million, with buyback prices from HKD 13.52 to HKD 13.76 [7] - Kuaishou-W (01024.HK) repurchased 1.235 million shares for HKD 80.2 million, with buyback prices ranging from HKD 64.35 to HKD 65.60 [7] - Geely Automobile (00175.HK) repurchased 1.908 million shares for HKD 31.8 million, with buyback prices between HKD 16.26 and HKD 16.8 [8]

英皇资本(00717)公布截至2025年9月30日止年度业绩，总收入约7.3亿港元，同比增长37.3%;净溢利约 1.47亿港元，同比增长121.4%;每股基本盈利为2.18港仙。 ...

年度宏观经济环境仍充满挑战且复杂，地缘政治紧张、债务问题、全球关税政策、通胀压力及高失业率 带来的诸多不利因素持续影响全球金融市场。鉴于资产减值风险不断增加及物业市场衰退加剧，企业盈 利及个人消费均受到抑制。因此，企业及个人均在股票市场及财富投资解决方案方面寻找其他投资机 遇。 格隆汇12月18日丨英皇资本(00717.HK)公告，2024/2025年度全年业绩，由于集团致力发展环球金融市 场业务分部，集团于年度的总收入增加37.3%至7.3亿港元。孖展贷款、其他贷款及垫款减值拨备净额 ("减值拨备")大幅减少至4320万港元(2024年：1.589亿港元)，因此，集团净溢利增至1.469亿港元(2024 年：6640万港元)。每股基本盈利为2.18港仙(2024年：0.98港仙)以及每股摊薄盈利为2.17港仙(2024年： 不适用)。 ...

智通财经APP讯，英皇资本(00717)公布截至2025年9月30日止年度业绩，总收入约7.3亿港元，同比增长 37.3%;净溢利约1.47亿港元，同比增长121.4%;每股基本盈利为2.18港仙。 ...

Financial Performance - Total revenue for the fiscal year ending September 30, 2025, increased by 37.3% to HKD 729.9 million, compared to HKD 531.6 million in 2024[5] - Revenue from the global financial markets segment surged by 94.5% to HKD 540.7 million, accounting for 74.1% of total revenue[10] - Net profit rose significantly by 121.4% to HKD 146.9 million, up from HKD 66.4 million in the previous year[6] - Total revenue for the year ended September 30, 2025, was HKD 729,872,000, an increase from HKD 531,628,000 in 2024, representing a growth of approximately 37.2%[22] - The group reported a pre-tax profit of HKD 146,926,000 for the year, compared to HKD 66,130,000 in 2024, reflecting a significant increase[22] - Basic earnings per share for the year were HKD 0.0218, up from HKD 0.0098 in 2024[22] - The company reported a pre-tax profit of HKD 146,936,000 for 2025, compared to HKD 66,361,000 in 2024, marking a 109.5% increase[45] - Basic earnings per share increased to HKD 2.18, up from HKD 0.98 in 2024, reflecting a growth of 122.4%[45] Revenue Breakdown - Commission and fee income contributed HKD 495,788,000, while interest income accounted for HKD 234,084,000, indicating strong performance in financial markets and lending segments[32] - The segment performance for financial markets showed a profit of HKD 66,554,000, while the lending segment reported HKD 110,309,000, leading to a total segment profit of HKD 178,513,000[33] - Commission and fee income from securities trading rose to HKD 84,425,000, up 53.1% from HKD 55,138,000 in 2024[39] - Interest income from margin financing and IPOs increased to HKD 55,291,000, up 27.0% from HKD 43,549,000 in 2024[39] Asset and Liability Management - As of September 30, 2025, the group's current assets and current liabilities were HKD 5,703,300,000 and HKD 2,304,300,000, respectively, compared to HKD 4,977,100,000 and HKD 1,813,500,000 in 2024[14] - The group reported a total cash and bank balance of HKD 2,353,800,000 as of September 30, 2025, up from HKD 1,520,800,000 in 2024[14] - Total assets increased to HKD 5,703,284 thousand in 2025, up from HKD 4,977,052 thousand in 2024, representing a growth of approximately 14.6%[23] - Current liabilities rose to HKD 2,304,295 thousand in 2025, compared to HKD 1,813,521 thousand in 2024, marking an increase of about 27.1%[23] - Net current assets improved to HKD 3,398,989 thousand in 2025, up from HKD 3,163,531 thousand in 2024, reflecting a growth of approximately 7.4%[23] - Non-current assets decreased to HKD 221,345 thousand in 2025 from HKD 296,774 thousand in 2024, a decline of about 25.4%[23] - The company’s total liabilities increased to HKD 3,482,128 thousand in 2025, up from HKD 2,267,746 thousand in 2024, reflecting a rise of approximately 53.4%[23] Impairment and Provisions - The impairment provision decreased by 72.8% to HKD 43.2 million, compared to HKD 158.9 million in 2024[5] - The impairment provision for the year was HKD 43,200,000, significantly lower than HKD 158,900,000 in 2024[16] - The group recognized a net impairment provision of approximately HKD 113,400,000 for loans and advances due to credit impairment stages[18] - Impairment provisions for loans and advances decreased to HKD 913,633,000 in 2025 from HKD 840,261,000 in 2024, indicating improved asset quality[48] Corporate Actions and Future Outlook - The company completed the acquisition of Crosby Asia Limited, enhancing its institutional financial services and research capabilities[10] - The outlook for the company remains positive, with expectations of increased IPO applications driven by Chinese tech companies attracting global investors[13] - The company plans to strengthen its global financial markets team to drive growth in brokerage, wealth management, and asset management services[13] - The successful implementation of the new Capital Investment Entrant Scheme (CIES) is expected to provide significant opportunities for tailored investment services[9] Dividend and Shareholder Information - The board has decided not to recommend any final dividend for the year, consistent with 2024[21] - The company did not declare any dividends for 2025, consistent with 2024[44] - The company’s issued and paid-up share capital remains at HKD 67,408,000 as of September 30, 2025, unchanged from the previous year[57] Compliance and Governance - The independent auditor confirmed that the financial statements for the year ended September 30, 2025, are in accordance with applicable accounting standards[60] - The company has adopted its own code of conduct for securities trading, which meets or exceeds the standards set out in the Listing Rules Appendix C3[62] - The annual performance announcement has been published on the Hong Kong Stock Exchange website and the company's website[64]

Group 1 - The core point of the article is the appointment of Mr. Zhu Yunming as an executive director and member of the executive committee of Emperor Capital, effective from January 1, 2026 [1]

格隆汇12月17日丨英皇资本(00717.HK)宣布，朱允明将获委任为公司执行董事及执行委员会成员，自 2026年1月1日起生效。 ...